Quest Diagnostics Incorporated (DGX): Price and Financial Metrics

DGX POWR Grades

• DGX scores best on the Quality dimension, with a Quality rank ahead of 94.28% of US stocks.
• The strongest trend for DGX is in Momentum, which has been heading down over the past 163 days.
• DGX ranks lowest in Momentum; there it ranks in the 16th percentile.

DGX Stock Summary

• With a market capitalization of $16,827,298,338, Quest Diagnostics Inc has a greater market value than 86.33% of US stocks.
• DGX's current price/earnings ratio is 7.7, which is higher than just 15.69% of US stocks with positive earnings.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for DGX comes in at 17.04% -- higher than that of 88.55% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Quest Diagnostics Inc are DAR, PKG, AMCR, FOXA, and TREX.
• DGX's SEC filings can be seen here. And to visit Quest Diagnostics Inc's official web site, go to www.questdiagnostics.com.

DGX Valuation Summary

• In comparison to the median Healthcare stock, DGX's EV/EBIT ratio is 75.09% lower, now standing at 7.3.
• Over the past 243 months, DGX's price/sales ratio has gone down 0.
• Over the past 243 months, DGX's price/sales ratio has gone down 0.

Below are key valuation metrics over time for DGX.

DGX Growth Metrics

The 3 year revenue growth rate now stands at 0.28%.
• Its 3 year net cashflow from operations growth rate is now at 43.73%.
• Its year over year revenue growth rate is now at 34.97%.

DGX's revenue has moved up $3,412,000,000 over the prior 49 months.

The table below shows DGX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	11,046	2,293	2,184
2021-06-30	11,058	2,594	2,247
2021-03-31	10,335	2,489	1,801
2020-12-31	9,437	2,005	1,431
2020-09-30	8,361	1,812	1,105
2020-06-30	7,531	1,249	752

DGX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• DGX has a Quality Grade of B, ranking ahead of 93.32% of graded US stocks.
• DGX's asset turnover comes in at 0.812 -- ranking 31st of 81 Healthcare stocks.
• SSY, LH, and BIOC are the stocks whose asset turnover ratios are most correlated with DGX.

The table below shows DGX's key quality metrics over time.